BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

335 related articles for article (PubMed ID: 23700236)

  • 21. Type 2 diabetes control in a nonobese rat model using sleeve gastrectomy with duodenal-jejunal bypass (SGDJB).
    Sun D; Liu S; Zhang G; Chen W; Yan Z; Hu S
    Obes Surg; 2012 Dec; 22(12):1865-73. PubMed ID: 22911149
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Exclusion of the Distal Ileum Cannot Reverse the Anti-Diabetic Effects of Duodenal-Jejunal Bypass Surgery.
    Chai J; Zhang G; Liu S; Hu C; Han H; Hu S; Zhang Z
    Obes Surg; 2016 Feb; 26(2):261-8. PubMed ID: 26024737
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mechanism of bile acid-regulated glucose and lipid metabolism in duodenal-jejunal bypass.
    Chai J; Zou L; Li X; Han D; Wang S; Hu S; Guan J
    Int J Clin Exp Pathol; 2015; 8(12):15778-85. PubMed ID: 26884847
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Surgical control of obesity and diabetes: the role of intestinal vs. gastric mechanisms in the regulation of body weight and glucose homeostasis.
    Patel RT; Shukla AP; Ahn SM; Moreira M; Rubino F
    Obesity (Silver Spring); 2014 Jan; 22(1):159-69. PubMed ID: 23512969
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Roux-en-Y Gastric Bypass Improves Metabolic Conditions in Association with Increased Serum Bile Acids Level and Hepatic Farnesoid X Receptor Expression in a T2DM Rat Model.
    Yan Y; Sha Y; Huang X; Yuan W; Wu F; Hong J; Fang S; Huang B; Hu C; Wang B; Zhang X
    Obes Surg; 2019 Sep; 29(9):2912-2922. PubMed ID: 31079286
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Down-Regulation of Renal Gluconeogenesis in Type II Diabetic Rats Following Roux-en-Y Gastric Bypass Surgery: A Potential Mechanism in Hypoglycemic Effect.
    Wen Y; Lin N; Yan HT; Luo H; Chen GY; Cui JF; Shi L; Chen T; Wang T; Tang LJ
    Obes Facts; 2015; 8(2):110-24. PubMed ID: 25832593
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Duodenal-jejunal bypass improves glycemia and decreases SGLT1-mediated glucose absorption in rats with streptozotocin-induced type 2 diabetes.
    Jurowich CF; Rikkala PR; Thalheimer A; Wichelmann C; Seyfried F; Sander V; Kreissl M; Germer CT; Koepsell H; Otto C
    Ann Surg; 2013 Jul; 258(1):89-97. PubMed ID: 23478528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The utility of [(11)C] dihydrotetrabenazine positron emission tomography scanning in assessing beta-cell performance after sleeve gastrectomy and duodenal-jejunal bypass.
    Inabnet WB; Milone L; Harris P; Durak E; Freeby MJ; Ahmed L; Sebastian M; Lifante JC; Bessler M; Korner J
    Surgery; 2010 Feb; 147(2):303-9. PubMed ID: 19828168
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preserve common limb in duodenal-jejunal bypass surgery benefits rats with type 2-like diabetes.
    Zhang SY; Sun XJ; Zheng JB; Wang W; Liu D; Chen NZ; He S; Huo XW; Smith W
    Obes Surg; 2014 Mar; 24(3):405-11. PubMed ID: 24190437
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Berberine inhibits hepatic gluconeogenesis via the LKB1-AMPK-TORC2 signaling pathway in streptozotocin-induced diabetic rats.
    Jiang SJ; Dong H; Li JB; Xu LJ; Zou X; Wang KF; Lu FE; Yi P
    World J Gastroenterol; 2015 Jul; 21(25):7777-85. PubMed ID: 26167077
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Duodenal long noncoding RNAs are associated with glycemic control after bariatric surgery in high-fat diet-induced diabetic mice.
    Liang Y; Yu B; Wang Y; Qiao Z; Cao T; Zhang P
    Surg Obes Relat Dis; 2017 Jul; 13(7):1212-1226. PubMed ID: 28366671
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Duodenal-jejunal bypass surgery does not increase skeletal muscle insulin signal transduction or glucose disposal in Goto-Kakizaki type 2 diabetic rats.
    Gavin TP; Sloan RC; Lukosius EZ; Reed MA; Pender JR; Boghossian V; Carter JJ; McKernie RD; Parikh K; Price JW; Tapscott EB; Pories WJ; Dohm GL
    Obes Surg; 2011 Feb; 21(2):231-7. PubMed ID: 21086062
    [TBL] [Abstract][Full Text] [Related]  

  • 33. miR-200a regulates Rheb-mediated amelioration of insulin resistance after duodenal-jejunal bypass.
    Guo W; Han H; Wang Y; Zhang X; Liu S; Zhang G; Hu S
    Int J Obes (Lond); 2016 Aug; 40(8):1222-32. PubMed ID: 27121251
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Roux-en-Y Gastric Bypass Surgery Suppresses Hepatic Gluconeogenesis and Increases Intestinal Gluconeogenesis in a T2DM Rat Model.
    Yan Y; Zhou Z; Kong F; Feng S; Li X; Sha Y; Zhang G; Liu H; Zhang H; Wang S; Hu C; Zhang X
    Obes Surg; 2016 Nov; 26(11):2683-2690. PubMed ID: 27038047
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Duodenal-jejunal bypass normalizes pancreatic islet proliferation rate and function but not hepatic steatosis in hypothalamic obese rats.
    Cantelli KR; Soares GM; Ribeiro RA; Balbo SL; Lubaczeuski C; Boschero AC; Araújo AC; Bonfleur ML
    Braz J Med Biol Res; 2017 Mar; 50(5):e5858. PubMed ID: 28380195
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Duodenal-jejunal bypass protects GK rats from {beta}-cell loss and aggravation of hyperglycemia and increases enteroendocrine cells coexpressing GIP and GLP-1.
    Speck M; Cho YM; Asadi A; Rubino F; Kieffer TJ
    Am J Physiol Endocrinol Metab; 2011 May; 300(5):E923-32. PubMed ID: 21304061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Renal function is ameliorated in a diabetic nephropathy rat model through a duodenal-jejunal bypass.
    Zhiqing W; Jing W; Haili X; Shaozhuang L; Chunxiao H; Haifeng H; Hui W; Sanyuan H
    Diabetes Res Clin Pract; 2014 Jan; 103(1):26-34. PubMed ID: 24398318
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Duodenal-jejunal bypass improves nonalcoholic fatty liver disease independently of weight loss in rodents with diet-induced obesity.
    Angelini G; Castagneto-Gissey L; Casella-Mariolo J; Caristo ME; Russo MF; Lembo E; Verrastro O; Stefanizzi G; Marini PL; Casella G; Bornstein SR; Rubino F; Mingrone G
    Am J Physiol Gastrointest Liver Physiol; 2020 Oct; 319(4):G502-G511. PubMed ID: 32812775
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Preserving Duodenal-Jejunal (Foregut) Transit Does Not Impair Glucose Tolerance and Diabetes Remission Following Gastric Bypass in Type 2 Diabetes Sprague-Dawley Rat Model.
    Dolo PR; Yao L; Li C; Zhu X; Shi L; Widjaja J
    Obes Surg; 2018 May; 28(5):1313-1320. PubMed ID: 29098544
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Jejunal long noncoding RNAs are associated with glycemic control via gut-brain axis after bariatric surgery in diabetic mice.
    Liang Y; Yu B; Wang Y; Qiao Z; Cao T; Zhang P
    Surg Obes Relat Dis; 2018 Jun; 14(6):821-832. PubMed ID: 29631984
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 17.